Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Two-Step Approach for the Prediction of Future Type 2 Diabetes Risk

Muhammad A. Abdul-Ghani, MD, Tamam Abdul-Ghani, MSC, Michael P. Stern, MD, Jasmina Karavic, Tiinamaija Tuomi, MD, Insoma Bo, MD, Ralph A. DeFronzo, MD, Leif Groop, MD

Diabetes Care 2011;34(9):2108–2112

https://doi.org/10.2337/dc10-2201

Published: 19 August 2011

View article titled, Two-Step Approach for the Prediction of Future Type 2 Diabetes Risk

Journal Articles

Insulin Assay Standardization: Leading to measures of insulin sensitivity and secretion for practical clinical care

Myrlene A. Staten, MD, Michael P. Stern, MD, W. Greg Miller, PHD, Michael W. Steffes, MD, PHD, Scott E. Campbell, PHD, for the Insulin Standardization Workgroup

Diabetes Care 2010;33(1):205–206

https://doi.org/10.2337/dc09-1206

Published: 01 January 2010

View article titled, Insulin Assay Standardization: <subtitle>Leading to measures of insulin sensitivity and secretion for practical clinical care</subtitle>

Journal Articles

Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose

Muhammad A. Abdul-Ghani, MD, PHD, Michael P. Stern, MD, Valeriya Lyssenko, MD, PHD, Tiinamaija Tuomi, MD, PHD, Leif Groop, MD, Ralph A. DeFronzo, MD

Diabetes Care 2010;33(3):557–561

https://doi.org/10.2337/dc09-1145

Published: 10 December 2009

View article titled, Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose

Journal Articles

Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes: A population-based study

Monica Nannipieri, MD, Rosalinda Posadas, PHD, Alessandra Bonotti, BM, Ken Williams, Clicerio Gonzalez-Villalpando, MD, Michael P. Stern, MD, Ele Ferrannini, MD

Diabetes Care 2006;29(11):2509–2511

https://doi.org/10.2337/dc06-0355

Published: 01 November 2006

View article titled, Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin <em>SNP45</em> Polymorphism, Predicts Type 2 Diabetes: <subtitle>A population-based study</subtitle>

Journal Articles

Family History of Type 2 Diabetes Is Associated With Increased Carotid Artery Intimal-Medial Thickness in Mexican Americans

W.H. Linda Kao, PHD, Wen-Chi Hsueh, PHD, David L. Rainwater, PHD, Daniel H. O’Leary, MD, Ikhide G. Imumorin, PHD, Michael P. Stern, MD, Braxton D. Mitchell, PHD

Diabetes Care 2005;28(8):1882–1889

https://doi.org/10.2337/diacare.28.8.1882

Published: 01 August 2005

View article titled, Family History of Type 2 Diabetes Is Associated With Increased Carotid Artery Intimal-Medial Thickness in Mexican Americans

Journal Articles

Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes : The Mexico City Diabetes Study

Monica Nannipieri, MD, Clicerio Gonzales, MD, Simona Baldi, PHD, Rosalinda Posadas, PHD, Ken Williams, MSC, Steven M. Haffner, MD, Michael P. Stern, MD, Ele Ferrannini, MD

Diabetes Care 2005;28(7):1757–1762

https://doi.org/10.2337/diacare.28.7.1757

Published: 01 July 2005

View article titled, Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes : <subtitle>The Mexico City Diabetes Study</subtitle>

Journal Articles

Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

Michael P. Stern, MD, Ken Williams, MS, Clicerio González-Villalpando, MD, Kelly J. Hunt, PHD, Steven M. Haffner, MD

Diabetes Care 2004;27(11):2676–2681

https://doi.org/10.2337/diacare.27.11.2676

Published: 01 November 2004

View article titled, Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

Includes: Supplementary data

Journal Articles

Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance

James B. Meigs, MD MPH, Ken Williams, MS, Lisa M. Sullivan, PHD, Kelly J. Hunt, PHD, Steven M. Haffner, MD, Michael P. Stern, MD, Clicerio González Villalpando, MD, Jessica S. Perhanidis, MPH, David M. Nathan, MD, Ralph B. D’Agostino, Jr, PHD, Ralph B. D’Agostino, Sr, PHD, Peter W.F. Wilson, MD

Diabetes Care 2004;27(6):1417–1426

https://doi.org/10.2337/diacare.27.6.1417

Published: 01 June 2004

View article titled, Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance

Journal Articles

The Metabolic Syndrome as Predictor of Type 2 Diabetes: The San Antonio Heart Study

Carlos Lorenzo, MD, Mayor Okoloise, MS, Ken Williams, MS, Michael P. Stern, MD, Steven M. Haffner, MD

Diabetes Care 2003;26(11):3153–3159

https://doi.org/10.2337/diacare.26.11.3153

Published: 01 November 2003

View article titled, The Metabolic Syndrome as Predictor of Type 2 Diabetes: <subtitle>The San Antonio Heart Study</subtitle>

Journal Articles

A Population Perspective on Diabetes Prevention: Whom should we target for preventing weight gain?

James P. Burke, PHD, Ken Williams, MS, K.M. Venkat Narayan, MD, Cynthia Leibson, PHD, Steven M. Haffner, MD, Michael P. Stern, MD

Diabetes Care 2003;26(7):1999–2004

https://doi.org/10.2337/diacare.26.7.1999

Published: 01 July 2003

View article titled, A Population Perspective on Diabetes Prevention: <subtitle>Whom should we target for preventing weight gain?</subtitle>

Journal Articles

Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes?

Michael P. Stern, MD, Ken Williams, MS, Steven M. Haffner, MD, MPH

Diabetes Care 2003;26(3):940–941

https://doi.org/10.2337/diacare.26.3.940

Published: 01 March 2003

View article titled, Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes?

Journal Articles

Predicting Future Cardiovascular Disease: Do we need the oral glucose tolerance test?

Michael P. Stern, MD, Pedram Fatehi, MPH, Ken Williams, MS, Steven M. Haffner, MD

Diabetes Care 2002;25(10):1851–1856

https://doi.org/10.2337/diacare.25.10.1851

Published: 01 October 2002

View article titled, Predicting Future Cardiovascular Disease: <subtitle>Do we need the oral glucose tolerance test?</subtitle>

Journal Articles

All-Cause and Cardiovascular Mortality Among Diabetic Participants in the San Antonio Heart Study: Evidence against the “Hispanic Paradox”

Kelly J. Hunt, PHD, Ken Williams, MS, Roy G. Resendez, MA, Helen P. Hazuda, PHD, Steve M. Haffner, MD, Michael P. Stern, MD

Diabetes Care 2002;25(9):1557–1563

https://doi.org/10.2337/diacare.25.9.1557

Published: 01 September 2002

View article titled, All-Cause and Cardiovascular Mortality Among Diabetic Participants in the San Antonio Heart Study: <subtitle>Evidence against the “Hispanic Paradox”</subtitle>

Journal Articles

Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease: The San Antonio Heart Study

Anthony J.G. Hanley, PhD, Ken Williams, MSc, Michael P. Stern, MD, Steven M. Haffner, MD

Diabetes Care 2002;25(7):1177–1184

https://doi.org/10.2337/diacare.25.7.1177

Published: 01 July 2002

View article titled, Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease: <subtitle>The San Antonio Heart Study</subtitle>

Journal Articles

Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico

James P. Burke, PHD, Ken Williams, MS, Steven M. Haffner, MD, Clicerio Gonzalez Villalpando, MD, FACP, Michael P. Stern, MD

Diabetes Care 2002;25(5):938–939

https://doi.org/10.2337/diacare.25.5.938

Published: 01 May 2002

View article titled, Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico

Journal Articles

Elevated Incidence of Type 2 Diabetes in San Antonio, Texas, Compared With That of Mexico City, Mexico

James P. Burke, PHD, Ken Williams, MS, Steven M. Haffner, MD, Clicerio Gonzalez Villalpando, MD, FACP, Michael P. Stern, MD

Diabetes Care 2001;24(9):1573–1578

https://doi.org/10.2337/diacare.24.9.1573

Published: 01 September 2001

View article titled, Elevated Incidence of Type 2 Diabetes in San Antonio, Texas, Compared With That of Mexico City, Mexico

Journal Articles

Reversion From Type 2 Diabetes to Nondiabetic Status: Influence of the 1997 American Diabetes Association criteria

James P Burke, PHD, Steven M Haffner, MD, Sharon P Gaskill, MPH, Kenneth L Williams, MS, Michael P Stern, MD

Diabetes Care 1998;21(8):1266–1270

https://doi.org/10.2337/diacare.21.8.1266

Published: 01 August 1998

View article titled, Reversion From Type 2 Diabetes to Nondiabetic Status: Influence of the 1997 American Diabetes Association criteria

Journal Articles

Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study

Ming Wei, MD, MPH, Sharon P Gaskill, MPH, Steven M Haffner, MD, Michael P Stern, MD

Diabetes Care 1998;21(7):1167–1172

https://doi.org/10.2337/diacare.21.7.1167

Published: 01 July 1998

View article titled, Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study

Journal Articles

Glycemia and Cardiovascular Risk

Michael P Stern, MD

Diabetes Care 1997;20(10):1501–1502

https://doi.org/10.2337/diacare.20.10.1501

Published: 01 October 1997

View article titled, Glycemia and Cardiovascular Risk

Journal Articles

The Homeostasis Model in the San Antonio Heart Study

Steven M Haffner, MD, Heikki Miettinen, MD, Michael P Stern, MD

Diabetes Care 1997;20(7):1087–1092

https://doi.org/10.2337/diacare.20.7.1087

Published: 01 July 1997

View article titled, The Homeostasis Model in the San Antonio Heart Study

NARROW

Two-Step Approach for the Prediction of Future Type 2 Diabetes Risk

Insulin Assay Standardization: Leading to measures of insulin sensitivity and secretion for practical clinical care

Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose

Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes: A population-based study

Family History of Type 2 Diabetes Is Associated With Increased Carotid Artery Intimal-Medial Thickness in Mexican Americans

Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes : The Mexico City Diabetes Study

Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance

The Metabolic Syndrome as Predictor of Type 2 Diabetes: The San Antonio Heart Study

A Population Perspective on Diabetes Prevention: Whom should we target for preventing weight gain?

Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes?

Predicting Future Cardiovascular Disease: Do we need the oral glucose tolerance test?

All-Cause and Cardiovascular Mortality Among Diabetic Participants in the San Antonio Heart Study: Evidence against the “Hispanic Paradox”

Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease: The San Antonio Heart Study

Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico

Elevated Incidence of Type 2 Diabetes in San Antonio, Texas, Compared With That of Mexico City, Mexico

Reversion From Type 2 Diabetes to Nondiabetic Status: Influence of the 1997 American Diabetes Association criteria

Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study

Glycemia and Cardiovascular Risk

The Homeostasis Model in the San Antonio Heart Study

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only